Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Revamps Strategy on Product Safety News

By Pharmaceutical Processing | October 1, 2009

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — The Food and Drug Administration is laying out plans to improve its public communications on food and drug safety, more than three years after federal advisers recommended major changes. The agency said it will begin studying public response to its announcements on potentially dangerous food and drugs. The plan posted online Wednesday takes its cue from a 2006 report by the Institute of Medicine, which found the FDA needed to do a better job communicating with the public. The nonprofit institute advises the federal government on medical issues. Problems with the FDA’s communications strategy were highlighted when the popular painkiller Vioxx was pulled from the market in 2004, five years after its approval, because of links to heart attack and stroke. The agency was criticized for not alerting the public earlier to those risks. While most patients understand the benefits of their medications, they know much less about the risks, said Bill Pierce, former spokesman for the Department of Health and Human Services. “I think this is just the latest step in a long-standing challenge for FDA which is: how do you communicate with public about the drugs they take?” said Pierce, now a consultant with APCO Worldwide, a public relations firm. The communication plan, begun during the George W. Bush administration, also offers Obama appointees a chance to renew the agency’s image, following a string of bungled drug and food safety recalls in recent years. “The FDA must communicate frequently and clearly about risks and benefits and inform patients and consumers about ways to minimize risk as they become increasingly involved in managing their health,” FDA Commissioner Margaret Hamburg said in a statement. Agency officials said it will take five years to implement the overhaul, which also will include: — Communication plans for crisis scenarios. — Using more video and Web-based materials to educate the public on safe food practices. The FDA already started notifying the public earlier about drug safety issues. Under its so-called early communication program, the agency issues announcements when it begins looking at potential side effect with a drug, even if no direct link has been established. Since its introduction in 2007, the policy has highlighted issues with several blockbuster medications, including Merck’s asthma drug Singulair, Pfizer’s smoking-cessation pill Chantix and GlaxoSmithKline’s weight loss pill alli. The agency ultimately added a “black box” warning to Chantix and bolstered language about suicidal behavior, depression and anxiety on Singulair. Glaxo’s alli is still under review.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE